Your browser doesn't support javascript.
Influenza Vaccination Reduces the Risk of Major Cardiovascular Events
Infectious Disease Alert ; 41(10), 2022.
Article in English | ProQuest Central | ID: covidwho-1898323
ABSTRACT
The ARR was 4.5% (95% CI, 2.6% to 6.4%;P < 0.001) with an NNT of 23 patients (95% CI, 16-39 patients) to prevent one cardiovascular event. [...]76 of the 4,510 patients (1.7%) who received the influenza vaccine died as a result of cardiovascular causes compared with 111 of the 4,491 patients (2.5%) who received placebo or control within one year of follow-up (RR, 0.74;95% CI, 0.42-1.30), although this result was not statistically significant (P = 0.29). [...]presumably none of the patients with influenza were co-infected with COVID-19, since only one study was conducted during the pandemic (2021). Unfortunately, the vaccine has to be reformulated before each influenza season because of mutations in viral surface proteins. [...]having a universally effective influenza vaccine would be a major advancement.
Keywords
Search on Google
Collection: Databases of international organizations Database: ProQuest Central Type of study: Prognostic study Topics: Vaccines Language: English Journal: Infectious Disease Alert Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Collection: Databases of international organizations Database: ProQuest Central Type of study: Prognostic study Topics: Vaccines Language: English Journal: Infectious Disease Alert Year: 2022 Document Type: Article